Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration

Explore clinical trials studying Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration trial results

Recruiting

A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors

NCT06716138

Conditions: Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration
Locations: Memorial Sloan Kettering Cancer Center New York, United States

Research Site Fuzhou, Fujian, China

Research Site Guangzhou, Guangdong, China

Research Site Shanghai, Shanghai Municipality, China

View Trial Details